Art
J-GLOBAL ID:201602254167652274   Reference number:16A1377745

Bortezomib increases CD20 expression of B cell lymphoma and enhances rituximab-mediated antitumor effect

ボルテゾミブはB細胞リンパ腫のCD20の発現を上昇させリツキシマブの抗腫瘍効果を高める。
Author (6):
Material:
Volume: 75th  Page: ROMBUNNO.P-2190 (WEB ONLY)  Publication year: 2016 
JST Material Number: U0661A  Document type: Proceedings
Article type: 会議録記事  Country of issue: Japan (JPN)  Language: ENGLISH (EN)
Thesaurus term:
Thesaurus term/Semi thesaurus term
Keywords indexed to the article.
All keywords is available on JDreamIII(charged).
On J-GLOBAL, this item will be available after more than half a year after the record posted. In addtion, medical articles require to login to MyJ-GLOBAL.
,...
Semi thesaurus term:
Thesaurus term/Semi thesaurus term
Keywords indexed to the article.
All keywords is available on JDreamIII(charged).
On J-GLOBAL, this item will be available after more than half a year after the record posted. In addtion, medical articles require to login to MyJ-GLOBAL.
,...
   To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=16A1377745&from=J-GLOBAL&jstjournalNo=U0661A") }}
JST classification (3):
JST classification
Category name(code) classified by JST.
Experimental treatment for tumors  ,  Basic research of antitumor(=antineoplastic)drugs  ,  Basic research of other drugs 
Substance index (1):
Substance index
Chemical Substance indexed to the Article.

Return to Previous Page